Skip to main content
Top
Published in: Journal of Nuclear Cardiology 3/2019

01-06-2019 | Cardiomyopathy | Images that Teach

Myocardial perfusion imaging in non-ischemic cardiomyopathy

Authors: Haren Patel, MD, Shane Prejean, MD, Ami E. Iskandrian, MD, MASNC, Fadi G. Hage, MD, MASNC

Published in: Journal of Nuclear Cardiology | Issue 3/2019

Login to get access

Excerpt

A 63-year-old African-American man was referred for exercise SPECT myocardial perfusion imaging (MPI) for the evaluation of non-exertional chest pain of 2-3 months duration that had worsened recently (occurring almost daily). He carries the diagnosis of dilated, non-ischemic cardiomyopathy (NICM) with left ventricular (LV) dysfunction by gated SPECT-MPI and 2-dimensional echocardiography (images not shown). His medication list is shown in Table 1.
Table 1
Baseline medication list
Aspirin 81 mg daily
Furosemide 40 mg daily
Carvedilol 25 mg twice daily
Irbesartan 300 mg daily
Digoxin 0.25 mg daily
Atorvastatin 20 mg daily
Potassium Chloride 10 mEq daily
Spironolactone 50 mg daily
Appendix
Available only for authorised users
Literature
1.
go back to reference Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14–9.CrossRefPubMed Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14–9.CrossRefPubMed
2.
go back to reference Caobelli F, Bengel FM. Ischaemic vs non-ischeamic dilated cardiomyopathy: the value of nuclear cardiology techniques. J Nucl Cardiol. 2015;5:971–4.CrossRef Caobelli F, Bengel FM. Ischaemic vs non-ischeamic dilated cardiomyopathy: the value of nuclear cardiology techniques. J Nucl Cardiol. 2015;5:971–4.CrossRef
4.
go back to reference Murthy V, Bateman T, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: Joint Position Paper on the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273–93.CrossRefPubMed Murthy V, Bateman T, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: Joint Position Paper on the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273–93.CrossRefPubMed
5.
go back to reference McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.CrossRefPubMed McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.CrossRefPubMed
6.
go back to reference Richardson T, Kronenberg M. Reversible myocardial perfusion abnormalities in nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2016;23:1183–5.CrossRefPubMed Richardson T, Kronenberg M. Reversible myocardial perfusion abnormalities in nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2016;23:1183–5.CrossRefPubMed
Metadata
Title
Myocardial perfusion imaging in non-ischemic cardiomyopathy
Authors
Haren Patel, MD
Shane Prejean, MD
Ami E. Iskandrian, MD, MASNC
Fadi G. Hage, MD, MASNC
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 3/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-01577-9

Other articles of this Issue 3/2019

Journal of Nuclear Cardiology 3/2019 Go to the issue